Revolution Medicines, Inc.
RVMD
$41.65
-$0.23-0.55%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -83.97% | -20.45% | -44.13% | -35.54% | -70.35% |
| Total Depreciation and Amortization | 38.69% | 20.68% | 39.67% | 65.10% | 10.30% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 12,088.79% | -35.90% | 48.47% | -13.78% | -101.75% |
| Change in Net Operating Assets | 105.16% | 98.62% | 478.72% | -122.28% | -1,500.98% |
| Cash from Operations | -21.10% | -14.70% | -29.77% | -90.95% | -157.34% |
| Capital Expenditure | -3.13% | 47.26% | -38.86% | -114.39% | -80.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 94.82% | -3.60% | -122.47% | 360.09% | -4,354.41% |
| Cash from Investing | 93.57% | -3.29% | -127.75% | 347.90% | -6,305.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10.12% | 30,461.63% | 7,545.30% | -88.39% | -99.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -88.62% | -- | -- | -- |
| Cash from Financing | 7.90% | 4.10% | 7,545.30% | -88.39% | -99.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 48.61% | 1.25% | -237.01% | 72.37% | -253.39% |